- The company is rapidly filling the void left by competitors in the subscription pain management device market.
- It is hiring sales representatives left, right and center, but it is still maintaining profitability and cash generation.
- The hiring will stop towards the end of the year, allowing profitability to seriously ramp next year.
- Despite some hopefully temporary headwinds from the pandemic, order growth has slowed from triple-digit territory to merely 50%+, we’ll argue that this should not really matter much, if at all.
Zynex Is A Winner
May 5th, 2020 · No Comments